TRxADE HEALTH (MEDS) Stock Chart & Stock Price History $1.07 -0.05 (-4.08%) As of 06/13/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock TRxADE HEALTH Stock Price Performance The TRxADE HEALTH (MEDS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.65%, with a year-to-date return of -82.75%. In the past month, the stock has increased 18.85%, reflecting recent market activity. As of the latest close, TRxADE HEALTH traded at $1.12 with a market cap of $1.57 million and volume of 111,282 shares. Five years ago, the stock traded at a split-adjusted price of $98.40, representing a 98.91% decrease over that period. At the time, it had a market cap of $50.45 million and a volume of 2,007 shares. Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.00%1 Month Performance+18.85%3 Month Performance-13.75%Year-To-Date Performance-82.75%1 Year Performance-83.65%5 Year Performance-98.91% MEDS Stock Chart for Monday, June, 16, 2025 MEDS Chart by TradingView TRxADE HEALTH Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$1.19$1.12-6.30%$1.16$1.06111,282 shs$1.57 million06/12/2025$1.15$1.19+3.48%$1.19$1.10202,143 shs$1.67 million06/11/2025$1.10$1.15+4.55%$1.17$1.10107,127 shs$1.62 million06/10/2025$1.06$1.10+3.77%$1.16$1.00181,695 shs$1.55 million06/09/2025$1.06$1.06$1.08$1.0099,337 shs$1.49 million06/06/2025$0.94$1.04+10.70%$1.09$0.94192,565 shs$1.46 million06/05/2025$0.84$0.94+11.45%$0.95$0.81167,701 shs$1.32 million06/04/2025$0.88$0.84-4.20%$0.88$0.8488,442 shs$1.19 million06/03/2025$0.87$0.88+0.65%$0.90$0.85110,998 shs$1.24 million06/02/2025$0.87$0.87$0.91$0.8741,775 shs$1.23 million Get the Latest News and Ratings for MEDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.93$0.91-2.57%$0.94$0.8843,077 shs$1.27 million05/29/2025$0.89$0.93+4.49%$0.93$0.8578,063 shs$1.31 million05/28/2025$0.88$0.89+1.55%$0.89$0.8334,408 shs$1.25 million05/27/2025$0.88$0.88$0.89$0.8562,368 shs$1.23 million05/26/2025$0.88$0.88$0.89$0.8562,368 shs$1.23 million05/23/2025$0.90$0.90$0.94$0.8776,356 shs$10.67 million05/22/2025$0.92$0.90-2.29%$0.94$0.8776,356 shs$1.27 million05/21/2025$0.95$0.92-2.94%$0.96$0.8970,270 shs$1.30 million05/20/2025$0.89$0.95+6.51%$0.98$0.83445,740 shs$1.33 million05/19/2025$0.89$0.89$0.93$0.8861,726 shs$1.25 million05/16/2025$0.91$0.90-1.00%$0.90$0.8619,645 shs$1.27 million05/15/2025$0.90$0.91+1.56%$0.94$0.8752,220 shs$1.28 million Related Companies JX Luxventure Group Inc. - Common Stock Stock Chart urban-gro Stock Chart Cheetah Net Supply Chain Service Stock Chart JX Luxventure Stock Chart Alkaline Water Stock Chart BIMI Stock Chart Cuentas Stock Chart Alliance Entertainment Stock Chart CHS Stock Chart CHS Stock Chart Receive MEDS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MEDS) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. Chinese AI chatbot DeepSeek turned the tech world on its hea...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDS Stock Free MEDS Stock Alerts